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Abstract  
Two-pore channel proteins, TPC1 and TPC2, are calcium permeable ion channels found 
localized to the membranes of endolysosomal calcium stores. There is increasing interest in 
the role of TPC-mediated intracellular signaling in various pathologies; however their role in 
breast cancer has not been extensively evaluated. TPC1 and TPC2 mRNA was present in all 
non-tumorigenic and tumorigenic breast cell lines assessed. Silencing of TPC2 but not TPC1 
attenuated epidermal growth factor-induced vimentin expression in MDA-MB-468 breast 
cancer cells. This effect was not due to a general inhibition of epithelial to mesenchymal 
transition (EMT) as TPC2 silencing had no effect on epidermal growth factor (EGF)-induced 
changes on E-cadherin expression. TPC1 and TPC2 were also shown to differentially 
regulate cyclopiazonic acid (CPA)-mediated changes in cytosolic free Ca2+. These findings 
indicate potential differential regulation of signaling processes by TPC1 and TPC2 in breast 
cancer cells.  
  
																																																								
 	Abbreviations: Ca2+, calcium; [Ca2+]CYT, cytosolic free calcium; EGF, epidermal growth 
factor; EMT, epithelial-mesenchymal transition; NAADP, nicotinic acid adenine dinucleotide 
phosphate; siNT, non-targeting siRNA; TPC1, two-pore channel protein 1; TPC2, two-pore 
channel protein 2; TRP, transient receptor potential 	
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1. Introduction  
The presence of specific Ca2+ channels is a feature of some cancer subtypes and in some 
cases silencing of proteins that constitute these channels can reduce cancer cell proliferation 
[1]. Examples include TRPV6 and Orai1, where silencing of these proteins alters Ca2+ 
signaling and attenuates the proliferation of breast cancer cells [2,3]. Studies of calcium 
channels in breast cancer cells have mostly focused on transient receptor potential (TRP), 
Orai, ligand-gated, and voltage-gated Ca2+ channels. Two-pore channel (TPC) proteins, 
TPC1 and TPC2, are recently identified ion channels that contribute to nicotinic acid adenine 
dinucleotide phosphate (NAADP)-mediated Ca2+ release from acidic intracellular 
endolysosomal stores [4]. TPC1 and TPC2 appear to have distinct gating mechanisms and 
have been reported to play differential roles in a variety of cell types and signaling pathways 
[4,5]. Despite the reported role of TPC1 in cell cycle regulation in a HEK293 overexpression 
model [6], and the role of TPC2, but not TPC1, in angiogenesis-associated signaling 
pathways [7], these channels have not been assessed in detail in breast cancer cell lines. 
However, evidence from studies in HER2 positive SKBR3 cells do suggest functional TPC 
channels in this breast cancer cell line [8]. 
 
Breast cancer is characterized by diversity at the prognostic, clinical and molecular level [9]. 
The triple negative breast cancer subtype, which overlaps largely with the basal molecular 
subtype, suffers from a lack of molecularly targeted therapies [9]. A number of triple 
negative breast cancer cell lines (such as MDA-MB-468 cells) have been used as in vitro 
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models for this subtype.  MDA-MB-468 cells belong to the related basal A cell line subgroup 
[10] and with appropriate stimuli, such as epidermal growth factor (EGF), can undergo an 
epithelial-mesenchymal transition (EMT), which is associated with a loss of epithelial 
markers such as E-cadherin and the gain of mesenchymal markers such as vimentin [11]. 
Recently, calcium signaling and specific Ca2+ permeable ion channels have been shown to be 
regulators of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells [12]. 
 
In this study we sought to determine if TPC1 and TPC2 were present in tumorigenic and non-
tumorigenic breast cell lines. We also assessed the consequences of TPC1 and TPC2 
silencing on the proliferation of MDA-MB-468 breast cancer cells, EGF-induced changes in 
the expression of vimentin and E-cadherin, and phosphorylation of STAT3. Finally, in light 
of recent evidence suggesting differential selectivity of TPC1 and TPC2 for Ca2+ ions 
[4,13,14], we assessed the consequences of channel silencing on calcium influx in the MDA-
MB-468 cell line.   
 
2. Materials and Methods  
 
2.1 Cell culture 
Human MDA-MB-468 and MDA-MB-231 breast cancer cells were cultured in high glucose 
DMEM (Sigma-Aldrich, St Louis, MO, USA) supplemented with 10% fetal bovine serum 
(FBS; Sigma-Aldrich) and L-glutamine (4 mM; Life Technologies, Carlsbad, CA, USA), and 
maintained in a humidified incubator at 37°C with 5% CO2. Cells consistently tested negative 
for mycoplasma infection (screened 6-monthly) using the MycoAlert Mycoplasma Detection 
Kit (Lonza Inc., Basel, Switzerland). For EMT studies, MDA-MB-468 cells were serum 
reduced (0.5% FBS) for 24 h prior to stimulation with EGF (50 ng/mL; E9644, Sigma-
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Aldrich) for the indicated time, as previously described [12], with the following changes: for 
EGF-stimulation protocols lasting greater than 48 h, media was replaced with fresh EGF after 
48 h. 
 
2.2 siRNA transfection 
siRNA-mediated gene silencing studies were performed using DharmaFECT4 Transfection 
Reagent and Dharmacon ON-TARGETplus SMARTpool siRNAs at a final concentration of 
100 nM (Thermo Scientific, Waltham, MA, USA), following the manufacturer’s protocols 
and as previously described [12]. The following siRNAs were used in this study: TPCN1 
(siTPC1; L-010710-00-0005), TPCN2 (siTPC2; L-006508-00-0005) and non-targeting 
control (siNT; D-001810-10-05). 
 
2.3 Real time RT-PCR 
Real time RT-PCR was performed as previously described [12], with the following changes: 
for Figs. 1A & B mRNA was amplified using TaqMan Universal PCR Master Mix (4324018; 
Applied Biosystems, Carlsbad, CA, USA), while TaqMan Fast Universal PCR Master Mix 
(4352042; Applied Biosystems) was used for Figs. 2A & B. RNA was isolated 48 or 96 h 
post-siRNA transfection for gene silencing studies. The following TaqMan Gene Expression 
assays were used to assess mRNA levels: TPC1 (Hs00330542_m1), TPC2 
(Hs01552063_m1), and 18S rRNA (4319413E; Applied Biosystems). Fold change (mRNA) 
was calculated using the comparative Ct method with 18S rRNA used as the endogenous 
control [15].  
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2.4 Immunoblotting 
Immunoblotting was performed as previously described [12]. Briefly, protein was loaded into 
NuPage Novex 4-12% bis-tris gels (Invitrogen) and run under reducing and denaturing 
conditions. Following protein transfer, PVDF membranes were blocked and incubated with 
primary antibody. The following antibodies were purchased from Cell Signaling Technology 
(Danvers, MA, USA): antiphospho-STAT3 (9138), anti-STAT3 (9139) (both diluted 1:1000). 
Anti-vimentin antibody (V6389) was purchased from Sigma-Aldrich (diluted 1:750). 
Membranes were then washed and probed with anti-mouse HRP-conjugated secondary 
antibody (170–6516, Bio-Rad Hercules, CA, USA) (diluted 1:10 000). Chemiluminescence 
imaging was performed using a Versadoc Imaging System (Bio-Rad). β-actin (A5441; 
Sigma-Aldrich) served as a loading control, and phosphorylated protein expression was 
further normalized relative to total protein concentration. Protein volume analysis was 
performed using Quantity One Software (Bio-Rad) using the global background subtraction 
method as outlined in the user manual. 
 
2.5 Cell enumeration and S-phase analysis 
At 96 h post-siRNA transfection, cell enumeration and S-phase analysis were performed by 
5-ethynyl-2’-deoxyuridine (EdU) incorporation using the Click-iT® EdU Alexa Fluor 555 
Imaging Kit (Invitrogen, Carlsbad, CA, USA) as previously described [16]. Cells were 
imaged with a 10X objective using an ImageXpress Micro automated epifluorescence 
microscope (Molecular Devices, Sunnyvale, CA, USA) using the following 
excitation/emission wavelengths: DAPI 377/447 nm and EdU 531/593. Normalized cell 
count and percent EdU positivity were determined using the Multi-wavelength cell scoring 
application module (MetaXpress v3.1.0.83; Molecular Devices).   
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2.6 Intracellular calcium measurements 
At 72 h post-siRNA transfection, measurement of cyclopiazonic acid (CPA)-mediated 
changes in store-operated calcium entry was performed using a fluorometric imaging plate 
reader (FLIPRTETRA; Molecular Devices) and the BD PBX no-wash calcium assay kit (BD 
Biosciences, Franklin Lakes, NJ, USA) as previously described [12].  
 
2.7 Statistical analysis 
Details of statistical analyses are provided in figure legends and were performed using 
GraphPad Prism version 6.05 for Windows.  
 
3. Results  
3.1 TPC isoform mRNA levels in a panel of breast cell lines 
TPC1 and TPC2 mRNA was detected in all tumorigenic and non-tumorigenic breast cell lines 
assessed. There was no clear trend for greater levels in tumorigenic breast cell lines compared 
to non-tumorigenic breast cell lines (184B5 and 184A1), or between subgroups such as 
luminal (MCF-7, T47D, ZR-75-1, BT-483), HER2 enriched (SKBR3) or basal/claudin low 
(MDA-MB-231, MDA-MB-468) [17,18] (Fig. 1). These results suggest that elevated TPC 
levels are not a defining characteristic of particular breast cancer cell line subgroups, which 
represent different breast cancer subtypes. 
 
3.2 Effect of TPC silencing on MDA-MB-468 breast cancer cell number 
To explore the potential role of TPC1 and TPC2 in a basal breast cancer cell line, TPC 
isoforms were selectively silenced in MDA-MB-468 breast cancer cells. TPC1 (Fig. 2A) and 
TPC2 (Fig. 2B) mRNA levels were effectively silenced at 48 h (>85%) and 96 h (>75%) 
post-siRNA transfection relative to the non-targeting siRNA control (siNT). At 96 h post 
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silencing, compensatory increases in the related isoform was observed (Fig. 2A and B). 
Silencing of TPC1 or TPC2 had no effect on cell number (Fig. 2C) or percentage of cells in 
S-phase (EdU positive) relative to the siNT control (Fig. 2D).    
  
3.3 TPC2 silencing attenuates EGF-induced vimentin expression in MDA-MB-468 cells 
The MDA-MB-468 breast cancer cell line is a commonly utilized in vitro model for the study 
of EMT in the context of defining responses to signals from the surrounding tumor 
microenvironment [11,19,20]. TPC2 but not TPC1 silencing significantly inhibited EGF-
induced vimentin expression relative to siNT in MDA-MB-468 cells (Fig. 3A). This effect 
was not due to a general inhibition of EMT induction since the suppression of E-cadherin 
expression by EGF was unaffected by TPC2 silencing (Fig. 3C). Inhibition of vimentin 
expression was specific to an induction pathway since TPC2 (like TPC1) silencing had no 
effect on the endogenous basal expression of vimentin protein in MDA-MB-231 breast 
cancer cells (Fig. 3B). However, effects of TPC2 on EGF-induced vimentin expression were 
not due to global suppression of EGF-induced signaling since TPC2 (like TPC1) silencing 
had no effect on activation of STAT3 by EGF (Fig. 3D). 
  
3.4 TPC isoform silencing differentially modulates calcium stores and/or store-operated 
calcium entry in MDA-MB-468 cells 
To assess the role of TPC isoforms in store-operated calcium entry, an important calcium 
influx pathway in epithelial cells [21], calcium stores of siRNA-transfected MDA-MB-468 
cells were depleted by CPA (10 µM) (an inhibitor of sarco/endoplasmic reticulum Ca2+-
ATPase channels) in order to activate plasma membrane localized store-operated channels 
(i.e. Orai1) (Fig. 4A & E). TPC1 silencing had no effect on CPA-induced calcium store 
release (peak 1) measured as change in relative cytosolic calcium (Fig. 4B) whereas TPC2 
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silencing resulted in significantly reduced CPA-induced calcium store release (Fig. 4F). 
TPC1 and TPC2 silencing also had opposing effects on store-operated calcium influx (peak 
2), observed through the re-addition of extracellular calcium (1.8 mM). TPC1 (Fig. 4C) 
modestly but significantly increased Ca2+ influx whereas TPC2 (Fig. 4G) silencing decreased 
Ca2+ influx associated with CPA-induced store depletion. These effects may be due in part to 
changes in CPA-induced depletion since the ratio of peak 2 to peak 1 (a measure of store-
operated Ca2+ entry) were not significantly altered by TPC1 or TPC2 silencing (Fig. 4D & 
H).  
 
4. Discussion  
These studies represent the first detailed assessment of TPC channels in breast cancer cells. 
Tumorigenic and non-tumorigenic breast cell lines had similar levels of TPC1 and TPC2 
mRNA. Unlike other ion channels, such as Orai1 [22], elevated levels of TPC channel 
mRNA does not seem to be a feature of breast cancer cells. Likewise, alterations in TPC1 and 
TPC2 mRNA were not a feature of a particular breast cancer cell molecular subtype. The 
similar levels of TPC1 and TPC2 among breast cell lines may be reflective of the diverse 
tissue distribution of these channels [23,24] and of important roles in epithelial cells. 
Assessment of the consequences of selective TPC isoform silencing in MDA-MB-468 breast 
cancer cells suggest some degree of gradual compensation between these isoforms, with 
TPC1 up-regulation following TPC2 silencing and vice versa at 96 h post knock-down. 
Unlike previous studies that show a role for TPC isoforms in cell cycle regulation when 
overexpressed in HEK293 cells [6], silencing of endogenous TPC expression had no effect 
on MDA-MB-468 cell proliferation, highlighting differences between endogenous and 
overexpressing systems.    
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The results presented here provide further evidence for specific and differential roles for TPC 
isoforms in the same cell type. TPC2 but not TPC1 silencing reduced EGF-induced vimentin 
expression in MDA-MB-468 breast cancer cells. TPC1 and TPC2 silencing also had different 
effects on CPA-mediated changes in [Ca2+]CYT. The gating and permeability of TPC1 and 
TPC2 vary [4] and examples of differential roles are also reflected in the effects of TPC 
isoform silencing on endomembrane dynamics [5],  effects of overexpression on multi-
nucleation [6], and roles on local and global Ca2+ signals [25]. In light of previous studies 
indicating a role for TPC2 in store-operated calcium entry [26], future studies assessing the 
mechanism by which TPC2 remodels CPA-induced changes in [Ca2+]CYT in this model are 
required, particularly in the context of calcium induced Ca2+ release [27]. 
 
The ability of TPC2 but not TPC1 to attenuate EGF-induced vimentin expression could have 
arisen from effects on EGF receptor trafficking given results of studies in TPC2 null mice 
[28].  However, this is unlikely given that EGF-mediated STAT3 activation was unaffected 
by TPC2 silencing in MDA-MB-468 breast cancer cells. Recent studies have identified the 
ability of JAK Inhibitor I to suppress EGF-induced vimentin expression in MDA-MB-468 
cells at concentrations that do not reduce EGF-activation of STAT3. Indeed, like TPC2 
silencing, JAK Inhibitor I does not reduce basal vimentin levels in MDA-MB-231 cells [29]. 
Future studies should now explore the potential association between TPC2 and the Janus 
kinase (JAK) signaling pathway in MDA-MB-468 cells. Despite the role of the Ca2+ signal in 
EMT induction and our report of effects of TPC2 silencing on the expression of the 
mesenchymal marker vimentin, TPC2 is clearly not a regulator of EMT induction, given that 
EGF-mediated changes in E-cadherin were not affected by TPC2 silencing [12]. 
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In summary, these studies provide further evidence for the ability of TPC1 and TPC2 to 
differentially regulate pathways in the same cell type and begin to define the role of these 
recently identified ion channels in breast cancer cells, including shaping responses to tumor 
micro-environmental factors such as EGF. 
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Figures/Figure legends 
 
Fig. 1. Relative mRNA levels of TPC isoforms in a panel of human breast cell lines. (A) 
TPC1 and (B) TPC2 mRNA levels in non-tumorigenic and tumorigenic breast cell lines were 
assessed using real time RT-PCR. Data were normalized to 18S rRNA and are expressed as 
fold-change relative to 184B5 cells. Bar graphs represent the mean ± S.D. for six wells from 
two independent experiments. 
 
Fig. 2. Effect of TPC1 or TPC2 silencing on MDA-MB-468 cell proliferation. Efficient 
siRNA-mediated silencing of (A) TPC1 or (B) TPC2 was shown at both 48 h (>85 %) and 96 
h (>75%). Bar graphs show percent TPC1 or TPC2 mRNA remaining relative to the non-
targeting control (siNT), and represent the mean ±SD from three independent experiments. 
Statistical analysis was performed using two-way ANOVA with Dunnett’s multiple 
comparisons test. The effect of TPC1 or TPC2 silencing on cell proliferation was assessed via 
(C) cell enumeration, shown relative to siNT, and (D) percentage S-phase (EdU positivity). 
Bar graphs represent the mean ±SD from three independent experiments. Statistical analysis 
was performed using one-way ANOVA with Dunnett’s multiple comparisons test. *P < 0.05. 
 
Fig. 3. TPC silencing in MDA-MB-468 and MDA-MB-231 breast cancer cells. The effect of 
TPC1 and TPC2 silencing on (A) Vimentin, (C) E-Cadherin and (D) STAT3 phosphorylation 
in MDA-MB-468 cells stimulated with EGF (50 ng/mL) for different times, and (B) basal 
vimentin protein expression in MDA-MB-231 cells at 72 h post knock down, was assessed 
using immunoblotting. (i) Representative blot and (ii) relative protein expression quantified 
from three independent experiments. MDA-MB-231 and MCF-7 protein lysates served as 
positive or negative controls in A(i) and C(i). Statistical analysis was performed using two-
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way ANOVA (A), (C) and (D) or one-way ANOVA (B) with Tukey’s multiple comparisons 
test. *P < 0.05, ns = not significant.  
 
Fig. 4. Effect of TPC1 or TPC2 silencing on store-operated calcium entry in MDA-MB-468 
cells. Calcium stores were depleted with cyclopiazonic acid (10 µM) in the presence of 
BAPTA (500 µM) (peak 1), resulting in activation of store-operated calcium entry channels 
and calcium influx upon addition of Ca2+ (1.8 mM) (peak 2). Calcium traces represent mean 
change (Δ) in relative [Ca2+]CYT in the presence of (A) TPC1 or (E) TPC2 silencing. Bar 
graphs show the mean ±SD for (B) & (F) peak 1 and (C) & (G) peak 2 relative [Ca2+]CYT,  
and (D) & (H) the ratio of peak 1 to peak 2 in the presence of TPC1 or TPC2 silencing. Data 
is representative of three independent experiments. Statistical analysis was performed using 
unpaired, two-tailed t test. *P < 0.05. 
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